Skip to content
522522522LLL

Drawing based on the label description. No photo yet.

“Ticagrelor tablet 90 mg is supplied as a yellow, round, biconvex, film-coated tablets debossed with '522' on one side and 'L' on other side”

522 L pill

Pill with imprint 522 L is yellow, round, 9 mm and has been identified as Ticagrelor 90 mg. It is supplied by Alembic Pharmaceuticals Inc.

Ticagrelor 90 mg

Imprint
522 L
Strength
90 mg
Color
Yellow
Shape
Round
Size
9 mm
Score
No score line
Form
Tablet, film coated
Manufacturer
Alembic Pharmaceuticals Inc
Drug class
Antiplatelet medicine (prevents clots)
NDC
62332-241, 62332-241-30, 62332-241-60, 62332-241-31, 62332-241-91, 46708-241, 46708-241-30, 46708-241-60, 46708-241-31, 46708-241-91, 67296-2268, 67296-2268-2, 67296-2268-6

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Ticagrelor pills and guides

What is Ticagrelor used for?

Ticagrelor is an antiplatelet medicine (prevents clots).

Medicine type
Antiplatelet medicine (prevents clots)
Official uses from the US prescribing label

Acute Coronary Syndrome or a History of Myocardial Infarction

Ticagrelor tablets are indicated to reduce the risk of cardiovascular (CV) death, myocardial infarction (MI), and stroke in patients with acute coronary syndrome (ACS) or a history of MI. For at least the first 12 months following ACS, it is superior to clopidogrel.

Ticagrelor tablet also reduces the risk of stent thrombosis in patients who have been stented for treatment of ACS.

Coronary Artery Disease but No Prior Stroke or Myocardial Infarction

Ticagrelor tablet is indicated to reduce the risk of a first MI or stroke in patients with coronary artery disease (CAD) at high risk for such events. While use is not limited to this setting, the efficacy of ticagrelor tablet was established in a population with type 2 diabetes mellitus (T2DM).

Acute Ischemic Stroke or Transient Ischemic Attack (TIA)

Ticagrelor tablet is indicated to reduce the risk of stroke in patients with acute ischemic stroke (NIH Stroke Scale score ≤5) or high-risk transient ischemic attack (TIA).

From the FDA-approved label on DailyMed (published Sep 30, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows 522 and the other side shows L.
  • It is yellow, round, 9 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Ticagrelor

Inactive: Mannitol, Dibasic Calcium Phosphate Dihydrate, Sodium Starch Glycolate Type A Potato, Povidone K30, Magnesium Stearate, Hypromellose 2910 (6 Mpa.s), Titanium Dioxide, Polyethylene Glycol 400, Talc, Ferric Oxide Yellow

Also distributed by

Alembic Pharmaceuticals Limited, Redpharm Drug

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Ticagrelor pills